Nonpharmacological therapies and provision of aids in outpatient dementia networks in Germany: utilization rates and associated factors

Markus Wübbeler1 Interventional Health Care Research Group, German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, GermanyCorrespondence[email protected]

Jochen René Thyrian1 Interventional Health Care Research Group, German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany

Bernhard Michalowsky2 German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany

Johannes Hertel2 German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany

Franziska Laporte Uribe3 Implementation and Dissemination Research Group, German Center for Neurodegenerative Diseases (DZNE), Witten, Germany

Karin Wolf-Ostermann4 Department of Human and Health Science, University of Bremen, Bremen, Germany

Susanne Schäfer-Walkmann6 Institute for Applied Social Sciences, Stuttgart, Germany

Wolfgang Hoffmann2 German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany;5 Epidemiology of Health Care and Community Health, Institute for Community Medicine, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany

show all

Nonpharmacological therapies and provision of aids in outpatient dementia networks in Germany: utilization rates and associated factors

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Nonpharmacological therapies and provision of aids in outpatient dementia networks in Germany: utilization rates and associated factors

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date